Recent/Key Publications

  • Brodin P, Del Nery E, Soleilhac E. High content screening in chemical biology: overview and main challenges. Med Sci (Paris). 2015 Feb;31(2):187-96
  • Mahmood SF, Gruel N, Chapeaublanc E, Lescure A, Jones T, Reyal F, Vincent-Salomon A, Raynal V, Pierron G, Perez F, Camonis J, Del Nery E, Delattre O, Radvanyi F, Bernard-Pierrot I. A siRNA screen identifies RAD21, EIF3H, CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation. Carcinogenesis. 2014, 35(3):670-82
  • Schauer K, Grossier JP, Duong T, Chapuis V, Degot S, Lescure A, Del Nery E, Goud B. A Novel Organelle Map Framework for High-Content Cell Morphology Analysis in High Throughput J. Biomol Screen. 2014 19(2):317-24
  • Ablain J, Leiva M, Peres L, Fonsart J, Anthony E, de Thé H. Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies. J. Exp Med. 2013 8;210(4):647-53
  • Boncompain G, Divoux S, Gareil N, de Forges H, Lescure A, Latreche L, Mercanti V, Jollivet F, Raposo G, Perez F. Synchronization of secretory protein traffic in populations of cells. Nat Methods. 2012;9(5):493-8
  • Pauwels E, Surdez D, Stoll G, Lescure A, Del Nery E, Delattre O, Stoven V. A probabilistic model for cell population phenotyping using HCS data. PLoS One. 2012;7(8)
  • Garcia-Cattaneo A, Gobert FX, Müller M, Toscano F, Flores M, Lescure A, Del Nery E, Benaroch P. Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling. Proc Natl Acad Sci U S A. 2012 5;109(23):9053-8